We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M Turnover 17.24%
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
+33.77%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$513M
AUM Growth
+$106M
Cap. Flow
+$6.06M
Cap. Flow %
1.18%
Top 10 Hldgs %
81.27%
Holding
82
New
6
Increased
9
Reduced
1
Closed
10
Avg Time Held
2.9 years
Top 10 Avg Time Held
1.9 years
Top 20 Avg Time Held
2.3 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 38.18%
2 Industrials 24.41%
3 Healthcare 15.1%
4 Materials 7.8%
5 Financials 5.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GLD icon
1
SPDR Gold Trust
GLD
$141B
$169M 32.92%
475,000
– –
2019 Q4
23 quarters
GPGI icon
2
GPGI Inc
GPGI
$3.61B
$81.6M 15.91%
3,919,466
– –
2022 Q1
14 quarters
LIN icon
3
Linde
LIN
$228B
$39M 7.6%
82,114
-2,100
-2% -$994K
2019 Q4
23 quarters
MDXH icon
4
MDxHealth
MDXH
$58.2M
$34.3M 6.69%
7,378,333
– –
2021 Q4
15 quarters
RHLD icon
5
Resolute Holdings Management
RHLD
$910M
$23.2M 4.52%
321,413
– –
2025 Q1
2 quarters
SPY icon
6
State Street SPDR S&P 500 ETF Trust
SPY
$813B
$21.7M 4.23%
32,570
+1,900
+6% +$1.22M
2023 Q4
7 quarters
BX icon
7
Blackstone
BX
$87.2B
$15.5M 3.02%
90,750
– –
2019 Q4
23 quarters
DUOT icon
8
Duos Technologies
DUOT
$175M
$12M 2.34%
1,627,806
– –
2020 Q1
22 quarters
IDN icon
9
Intellicheck
IDN
$45M
$10.8M 2.1%
2,073,583
– –
2019 Q4
23 quarters
INVE icon
10
INVE Technologies, Inc. Common Stock
INVE
$55.3M
$9.95M 1.94%
2,884,495
– –
2019 Q4
23 quarters
SPGI icon
11
S&P Global
SPGI
$125B
$9.73M 1.9%
20,000
– –
2019 Q4
23 quarters
LIQT icon
12
LiqTech
LIQT
$12.8M
$8.37M 1.63%
3,182,239
– –
2020 Q1
22 quarters
DTIL icon
13
Precision BioSciences
DTIL
$168M
$5.93M 1.16%
1,075,000
– –
2025 Q1
2 quarters
CUE icon
14
Cue Biopharma
CUE
$131M
$4.9M 0.96%
227,305
– –
2019 Q4
23 quarters
PROK icon
15
ProKidney
PROK
$305M
$4.84M 0.94%
2,000,000
– –
2022 Q3
12 quarters
BRFH icon
16
Barfresh Food Group
BRFH
$9.46M
$4.84M 0.94%
1,390,758
– –
2022 Q1
14 quarters
JPM icon
17
JPMorgan Chase
JPM
$888B
$4.73M 0.92%
15,000
– –
2019 Q4
23 quarters
EYPT icon
18
EyePoint Inc
EYPT
$267M
$3.65M 0.71%
256,515
– –
2025 Q2
1 quarter
WELL icon
19
Welltower
WELL
$169B
$3.56M 0.69%
20,000
– –
2025 Q2
1 quarter
NMTC icon
20
NeuroOne Medical Technologies
NMTC
$9.29M
$3.55M 0.69%
666,667
– –
2025 Q2
1 quarter
FLNT icon
21
Fluent
FLNT
$83.1M
$3.17M 0.62%
+1,428,571
New +$3.11M
2025 Q3
0 quarters
GNLX icon
22
Genelux
GNLX
$110M
$3M 0.58%
714,000
– –
2025 Q1
2 quarters
QQQ icon
23
Invesco QQQ Trust
QQQ
$484B
$2.79M 0.54%
4,640
+2,240
+93% +$1.28M
2025 Q2
1 quarter
TV icon
24
Televisa
TV
$1.31B
$2.77M 0.54%
1,030,000
– –
2021 Q2
17 quarters
DMAC icon
25
DiaMedica Therapeutics
DMAC
$438M
$2.63M 0.51%
382,317
– –
2023 Q2
9 quarters

Similar funds

Bleichroeder LP's Q3 2025 Portfolio in Review

As of Q3 2025, Bleichroeder LP held 82 positions worth $513M, up 26% from $407M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Bleichroeder LP's Q3 2025 filing shows 6 new, 9 increased, 1 reduced and 10 closed positions. Its largest new stake was Fluent: 1,428,571 shares worth $3.17M. The largest sale was Alpha Cognition, an estimated $1.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, down from 41% a quarter earlier, followed by Industrials and Healthcare.

  • Bleichroeder LP's largest Q3 2025 buy was Fluent: 1,428,571 shares worth $3.17M.
  • Bleichroeder LP added most to Invesco QQQ Trust in Q3 2025, an estimated $1.28M increase.
  • Bleichroeder LP's biggest Q3 2025 reduction was Linde, cutting an estimated $994K.
  • Bleichroeder LP fully exited Alpha Cognition in Q3 2025, selling an estimated $1.3M.
  • Bleichroeder LP's ten largest holdings make up 81% of its $513M portfolio in Q3 2025.
  • Bleichroeder LP opened 6 new positions and closed 10 in Q3 2025.
  • Bleichroeder LP's portfolio value rose 26% quarter-over-quarter to $513M.

Based on Bleichroeder LP's 13F filing for Q3 2025, filed 14 Nov 2025.